Skip to content

Investigator

John Danias

SUNY DOWNSTATE MEDICAL CENTER · funded by NEI, VA

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.3M

Summed across those awards.

First award
May 1, 2023

Latest Apr 1, 2025.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Elucidating the molecular changes of the outflow pathway extracellular matrix that regulate outflow facility in steroid-induced ocular hypertension and open angle glaucoma

    $662k

    Apr 1, 2025NEISUNY DOWNSTATE MEDICAL CENTERNIH RePORTER · 11028857 (opens the source filing in a new tab)

  2. R01

    Elucidating the molecular changes of the outflow pathway extracellular matrix that regulate outflow facility in steroid-induced ocular hypertension and open angle glaucoma

    $628k

    Apr 1, 2025NEISUNY DOWNSTATE MEDICAL CENTERNIH RePORTER · 11302646 (opens the source filing in a new tab)

  3. I01

    Tissue plasminogen activator for the treatment of glaucoma

    May 1, 2023VAVA NEW YORK HARBOR HLTHCARE/SYS/BROOKLYNNIH RePORTER · 11065469 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources